Pre-existing BCR-ABL mutations can be detected in a substantial number of chronic-phase CML patients by sensitive allele-specific PCR technique using CD34+ cells. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.